Showing results (1-10 of 259) with videos related to
Sort By:
Pageof 26
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2003
[Chronic allograft nephropathy: its diagnosis and treatment]Haruhito AzumaHinyokika Kiyo. Acta Urologica Japonica|January 19, 2013
[Verification of testicular cancer guidelines]Norio Nonomura, Haruhito AzumaHinyokika Kiyo. Acta Urologica Japonica|January 19, 2013
[Comprehensive management of residual tumor in patients with an advanced testicular tumor]Teruo Inamoto, Haruhito AzumaHinyokika Kiyo. Acta Urologica Japonica|February 12, 2008
[Molecular targeting therapy for bladder cancer]Haruhito Azuma, Yoji KatsuokaHinyokika Kiyo. Acta Urologica Japonica|July 20, 2006
[Treatment for locally advanced prostate cancer: value of surgery]Haruhito Azuma, Yoji KatsuokaJournal of Oncology|April 7, 2012
Immunotherapy of genitourinary malignanciesTeruo Inamoto, Haruhito AzumaTherapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 15, 2022
Clinical parameters of therapeutic apheresis induction in clinically amyopathic dermatomyositis patients with rapid progressive interstitial lung diseaseMaki Kagitani, Hayahito Nomi, Haruhito AzumaAsian Journal of Surgery|March 8, 2011
Clinical evaluation of minimum-incision endoscopic radical prostatectomy in initial 50 patientsShuji Hamada, Haruhito Azuma, Teruo Inamoto, et al.International Journal of Molecular Sciences|December 10, 2021
CRISPR Screen Contributes to Novel Target Discovery in Prostate CancerTakuya Tsujino, Kazumasa Komura, Teruo Inamoto, et al.Clinical Medicine Insights. Oncology|May 24, 2011
Rapid Increase of the Serum PSA Level in Response to High-Intensity Focused Ultrasound Therapy may be a Potential Indicator of Biochemical Recurrence of Low- and Intermediate-Risk Prostate CancerTeruo Inamoto, Kazumasa Komura, Toshikazu Watsuji, et al.Pageof 26